Literature DB >> 8146165

Fib420: a normal human variant of fibrinogen with two extended alpha chains.

Y Fu1, G Grieninger.   

Abstract

In fibrinogen, alpha E chains form a subpopulation of alpha subunits that are distinguished by a carboxyl extension homologous to the C termini of the other two constituent chains: beta and gamma. The molecular mass of alpha E is > 50% greater than that of the common alpha subunit, due in part to an extra 236 amino acids. These residues are encoded by exon VI, a recently discovered extension of the fibrinogen alpha gene. Additional mass is contributed by posttranslational processing, including N-glycosylation, which, based on experiments with the inhibitor tunicamycin, was found to account in large measure for alpha E migration on SDS/PAGE at approximately 110 kDa rather than at its calculated mass of 92,843 Da. An antibody specific for the exon VI-encoded domain of alpha E (anti-VI) and capable of recognizing alpha E-containing fibrinogen in both native and denatured form was generated using a recombinant protein as immunogen. Its use in Western blot analysis of fractions of normal human blood (plasma and preparations of fibrinogen) revealed a single, sharp, alpha E-containing band migrating behind the position of the broad, predominant fibrinogen band, (alpha beta gamma)2. Designation of the upper band as Fib420, an approximately 420-kDa homodimer of the formula (alpha E beta gamma)2, is based on the overwhelming proportion of alpha E subunits (> 80% of the total alpha chains) found in anti-VI-immunoprecipitable material from hepatoma cell medium. Several lines of evidence suggest that the alpha E subunit, alone or incorporated into fibrinogen, is more stable than the common alpha chain, a feature of potential clinical importance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146165      PMCID: PMC43422          DOI: 10.1073/pnas.91.7.2625

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  N-terminal disulphide knot of human fibrinogen.

Authors:  B Blombäck; M Blombäck; A Henschen; B Hessel; S Iwanaga; K R Woods
Journal:  Nature       Date:  1968-04-13       Impact factor: 49.962

2.  Human fibrinogen--structural variants and functional sites.

Authors:  A H Henschen
Journal:  Thromb Haemost       Date:  1993-07-01       Impact factor: 5.249

3.  Shadow-cast electron microscopy of fibrinogen with antibody fragments bound to specific regions.

Authors:  T M Price; D D Strong; M L Rudee; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

4.  Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy.

Authors:  M W Mosesson; J Hainfeld; J Wall; R H Haschemeyer
Journal:  J Mol Biol       Date:  1981-12-15       Impact factor: 5.469

5.  Observation of the alpha-chain extensions of fibrinogen through a new electron microscope specimen preparation technique.

Authors:  M L Rudee; T M Price
Journal:  Ultramicroscopy       Date:  1981       Impact factor: 2.689

6.  Laser diffraction of oriented fibrinogen molecules.

Authors:  R Gollwitzer; W Bode; H J Schramm; D Typke; R Guckenberger
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

7.  Electron microscopy of fibrinogen, its plasmic fragments and small polymers.

Authors:  H P Erickson; W E Fowler
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

8.  Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.

Authors:  H Nakabayashi; K Taketa; K Miyano; T Yamane; J Sato
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

9.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more
  12 in total

1.  Molecular analysis of scabrous mutant alleles from Drosophila melanogaster indicates a secreted protein with two functional domains.

Authors:  X Hu; E C Lee; N E Baker
Journal:  Genetics       Date:  1995-10       Impact factor: 4.562

2.  Crystal structure of a recombinant alphaEC domain from human fibrinogen-420.

Authors:  G Spraggon; D Applegate; S J Everse; J Z Zhang; L Veerapandian; C Redman; R F Doolittle; G Grieninger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  The minor form alpha' chain from lamprey fibrinogen is rapidly crosslinked during clotting.

Authors:  E Shipwash; Y Pan; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

Review 4.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

5.  Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia.

Authors:  Zhilian Hu; Kari I Lavik; Yang Liu; Andy H Vo; Catherine E Richter; Jorge Di Paola; Jordan A Shavit
Journal:  J Thromb Haemost       Date:  2019-02-25       Impact factor: 5.824

6.  A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen AαE in early hemostasis.

Authors:  Cristina Freire; Richard J Fish; Rui Vilar; Corinne Di Sanza; Steven J Grzegorski; Catherine E Richter; Jordan A Shavit; Marguerite Neerman-Arbez
Journal:  Blood Adv       Date:  2020-11-10

Review 7.  Fibrinogen αC domain: Its importance in physiopathology.

Authors:  Jeannette Soria; Shahsoltan Mirshahi; Sam Qiumars Mirshahi; Remi Varin; Linda L Pritchard; Claudine Soria; Massoud Mirshahi
Journal:  Res Pract Thromb Haemost       Date:  2019-02-15

8.  Impact of posttranslational modifications on atomistic structure of fibrinogen.

Authors:  Žofie Sovová; Jana Štikarová; Jiřina Kaufmanová; Pavel Májek; Jiří Suttnar; Pavel Šácha; Martin Malý; Jan E Dyr
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

9.  The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression.

Authors:  Joanna Kołodziejczyk; Michał B Ponczek
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

10.  Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain.

Authors:  Zofie Sovova; Jiri Suttnar; Jan E Dyr
Journal:  Metabolites       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.